Healthcare · Diagnostics Research · NASDAQ
| Market cap | $2.42B |
|---|---|
| Trailing P/E | 42.1 |
| FCF yield | 1.4% |
| Revenue growth (YoY) | +13.8% |
| EPS growth (YoY) | +11.1% |
| FCF/share growth (YoY) | +19.3% |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Diagnostics Research |
CareDx, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| Daniel Goldman | House | Sell | $1,001 - $15,000 | Apr 3, 2023 |
| Tom Malinowski | House | Buy | $15,001 - $50,000 | Apr 1, 2021 |
| Tom Malinowski | House | Buy | $1,001 - $15,000 | Jan 1, 2021 |
| Tom Malinowski | House | Buy | $1,001 - $15,000 | Jan 1, 2021 |
| Tom Malinowski | House | Buy | $1,001 - $15,000 | Jan 1, 2021 |
| Tom Malinowski | House | Buy | $1,001 - $15,000 | Dec 1, 2020 |
| Tom Malinowski | House | Sell | $1,001 - $15,000 | Jul 1, 2019 |
| Tom Malinowski | House | Sell | $1,001 - $15,000 | Jul 1, 2019 |
| Tom Malinowski | House | Buy | $1,001 - $15,000 | May 1, 2019 |
| Tom Malinowski | House | Sell | $15,001 | Apr 1, 2019 |